Key stats
About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA MEDTECH ETF
Expense ratio
0.68%
Home page
Inception date
Aug 3, 2023
ISIN
HK0000945649
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the Index).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Commercial Services
Stocks99.20%
Health Technology49.34%
Health Services21.78%
Commercial Services13.20%
Technology Services7.23%
Process Industries6.84%
Retail Trade0.80%
Bonds, Cash & Other0.80%
Cash0.80%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history